Autoimmune and Inflammatory Disease

Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study

Konkle KS et al., 2012

Interstitial cystitis is associated with vulvodynia and sexual dysfunction--a case-control study

Gardella B et al., 2011

Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand

Han DY et al., 2010

Celiac disease and its effect on human reproduction: a review

Soni S et al., 2010

Is preeclampsia an autoimmune disease?

Xia Y et al., 2009

Severity of interstitial cystitis symptoms and quality of life in female patients

El Khoudary SR et al., 2009

Epidemiology of Crohn's disease in Québec, Canada

Lowe AM et al., 2009

Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome

Warren JW et al., 2008

Interstitial cystitis and systemic autoimmune diseases

van de Merwe JP, 2007

Reproductive and menopausal factors and risk of systemic lupus erythematosus in women

Costenbader KH et al., 2007

Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population

Halfvarson J et al., 2006

Overt and 'subclinical' hypothyroidism in women

Wartofsky L et al., 2006

Risk factors for inflammatory bowel disease in the general population

García Rodríguez LA et al., 2005

Chapter 36: Thyroid System Dysfunction

Hilgers TW, 2004 · Book chapter

The presence of the antigliadin antibodies in autoimmune thyroid diseases

Akçay MN et al., 2003

Risk factors associated with systemic lupus erythematosis in a Mexican population

Zonana-Nacach A et al., 2002

Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study

Cooper GS et al., 2002

Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC)

Corrao G et al., 1998

Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC)

Parrello T et al., 1997

Past use of oral contraceptives and the risk of developing systemic lupus erythematosus

Sanchez-Guerrero J et al., 1997

Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease

Godet PG et al., 1995

The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey

Vanderpump MP et al., 1995

Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus

Strom BL et al., 1994

Risk indicators for inflammatory bowel disease

Persson PG et al., 1993

Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study

Lashner BA et al., 1989

Is endometriosis an autoimmune disease?

Gleicher N et al., 1987

Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age

Vessey M et al., 1986

Systemic lupus erythematosus and reproductive function: a case-control study

Grimes DA et al., 1985

Antiphospholipid syndrome in pregnancy: a comprehensive literature review

Murvai VR et al., 2025

Transvaginal Photobiomodulation Improves Pain in Women with Pelvic Muscle Tenderness and Interstitial Cystitis/Bladder Pain Syndrome: A Preliminary Observational Study

Butrick CW et al., 2022

Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis

Golianovskyi OV et al., 2020

Nutraceutical Supplements in the Thyroid Setting: Health Benefits beyond Basic Nutrition

Benvenga S et al., 2019

Low Dose Naltrexone in the Treatment of Fibromyalgia

Metyas SK et al., 2018

Low dose naltrexone for induction of remission in Crohn's disease

Parker CE et al., 2018

Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia

Parkitny L et al., 2017

Endometriosis: a high-risk population for major chronic diseases?

Kvaskoff M et al., 2015

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain

Younger J et al., 2014

Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial

Höfling DB et al., 2013

Low‐dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double‐blind, placebo‐controlled, counterbalanced, crossover trial assessing daily pain levels

Younger J et al., 2013

Low dose naltrexone: side effects and efficacy in gastrointestinal disorders

Ploesser J et al., 2010

Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study

Kariv R et al., 2006

Smoking and ovulation inhibitor in inflammatory bowel diseases

Katschinski B, 1993

Thyroid disease and reproductive dysfunction: a review

Thomas R et al., 1987